Angelini Ventures
Corporate venture capital arm of Angelini Industries, a major European pharmaceutical and consumer health conglomerate. Invests globally in health and wellness sectors with strategic focus on pharma innovation.
Location
Rome, Italy
Founded
2020
AUM
€300M+
Investment Range
€5M - €30M
Portfolio Companies
4
Focus
cvc
Fund Stages
seed, series-a, series-b, series-c
Investment Thesis
Angelini Ventures invests in companies developing innovative solutions in health and wellness, with focus areas aligned to Angelini Industries' strategic interests in pharmaceuticals, consumer health, and healthcare technology. They provide both capital and strategic partnership opportunities with their parent company.
Team
Partners / Managing Directors (Health & Bio Focus)
- Alessandro Paganelli - CEO
- Cristiano Bernasconi - Investment Director
Other Key Team Members
- Investment team with pharma industry expertise
Focus Areas
- Pharmaceuticals
- Consumer Health
- Digital Health
- Medical Devices
- Mental Health
- Women's Health
- Wellness Technology
Notable Exits
- Portfolio companies in development and growth stage
- Strategic partnerships with Angelini Industries portfolio
Sources
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| VANTIS | Europe | 2022 | healthcare-platformhybrid-care+1 |
| NEUmiRNA Therapeutics | Netherlands | 2018 | biotechtherapeutics+2 |
| Nouscom | Basel, Switzerland & Rome, Italy | 2015 | biotechoncology+2 |
| Avation Medical | Atlanta, Georgia, USA | 2017 | medical-devicesurology+2 |